[Adriamycin instillations in carcinoma in situ of the bladder].
Several authors have described the regressive effect of the instillation of adriamycin on the cell appearance of carcinoma in situ. This applies to both weekly and monthly administration. The problem lies in the interpretation of the cytologic picture after instillation. DNA analysis could possibly improve the diagnostic reliability.
D002278:Carcinoma in Situ / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D003581:Cytodiagnosis; D004273:DNA, Neoplasm / Q000032:analysis; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D013997:Time Factors; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology
D004273:DNA, Neoplasm; D004317:Doxorubicin
Adriamycin-Instillationen bei Carcinoma in situ der Harnblase.